Form 4 for HCAT Health Catalyst, Inc.

Accepted 2022-03-03 00:00:00 ET · period of report 2022-03-01 · accession 0001562180-22-002344 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
M	2022-03-03	2022-03-01+	HCAT	Llewelyn Linda	CHRO	F - Tax	$26.64	-1,414	66.3K	-2%	-$37.7K
	2022-03-03	2022-03-01	HCAT	Llewelyn Linda	CHRO	A - Grant	$0.00	+1,861	66.5K	+3%	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2022-03-01	F	D	1,216	$26.63	64,666	D	—	—	(F2) Represents the weighted average sale price of the shares sold ranging from $26.23 to $27.44 per share, inclusive.
2	Common	Common Stock	2022-03-01	A	A	1,861	$0.00	66,527	D	—	—	(F3) Represents an award of 1,861 performance-based restricted units ("PRSUs") pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each PRSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan and Issuer's satisfaction of certain performance criteria for the fiscal year ended December 31, 2021, the PRSUs noted above vested on March 1, 2022.
3	Common	Common Stock	2022-03-02	F	D	198	$26.69	66,329	D	—	—	(F4) Represents the weighted average sale price of the shares sold ranging from $25.29 to $27.56 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (2) and (4).